Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
New therapy with unique bacterial strain B. bifidum HI-MIMBb75 promises help for approximately 80 million Europeans suffering from irritable bowel syndrome1 World's largest clinical OTC irritable bowel syndrome trial investigating the efficacy of this particular strain published in the renowned medical journal The Lancet Gastroenterology & Hepatology2 Results show significant efficacy for all predominant irritable bowel syndrome symptoms and all subtypes while simultaneously improving patients’ quality of life2 (Gräfelfing/Munich, Germany) The world's largest OTC irritable bowel syndrome (IBS) trial comes up with remarkable results, which were recently published in the renowned medical journal The Lancet Gastroenterology & Hepatology. For the first time, leading German scientists around Prof. Dr. Peter Layer (Israelitic Hospital Hamburg) were able to prove the significant efficacy of a heat-inactivated bacterial strain on patients with IBS. Trial results show that B. bifidum HI-MIMBb75
Irritable Bowel Syndrome with Constipation
Clinical Trials and Studies - IFFGD
Electroceuticals in the Gastrointestinal Tract: Trends in Pharmacological Sciences
Pharmaceuticals, Free Full-Text
The neurobiology of irritable bowel syndrome
Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth: Exploring the Relationship - McIsaac Health Systems Inc.
10 Inflammatory Bowel Disease (IBD) Nursing Care Plans - Nurseslabs
Frontiers Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
Management of the multiple symptoms of irritable bowel syndrome - The Lancet Gastroenterology & Hepatology